Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MkII Inserter and FAI Insert in Non-Infectious Uveitis
NCT02748512Phase 3Completed
- Sponsor
- EyePoint Pharmaceuticals
- Start
- Feb 2016
- Primary completion
- Aug 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluocinolone acetonide intravitreal implant in noninfectious uveitis (NIU), sponsored by EyePoint Pharmaceuticals. Started Feb 2016; status: completed.
02
Drugs
fluocinolone acetonide intravitreal implant
03
Conditions
noninfectious uveitis (NIU)
Beyond the preview
Go deeper on NCT02748512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02748512.